Digestive & Intestinal Remedies (Pharmacies) - Oman

  • Oman
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$23.83m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.48%, resulting in a market volume of US$25.65m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$5.06 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Oman has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Oman have shown a growing demand for natural and herbal remedies. Consumers are increasingly seeking products that are derived from natural ingredients and have fewer side effects. This preference for natural remedies has been influenced by global trends towards healthier lifestyles and a growing awareness of the potential risks associated with synthetic medications. As a result, there has been an increase in the availability and popularity of natural digestive and intestinal remedies in Oman. Trends in the market indicate a shift towards self-care and preventive healthcare. Consumers are becoming more proactive in managing their health and are seeking remedies that can help prevent digestive and intestinal issues before they occur. This trend is driven by a desire to reduce healthcare costs and improve overall well-being. As a result, there has been an increase in the demand for over-the-counter digestive and intestinal remedies that can be easily accessed and used without a prescription. Local special circumstances in Oman have also contributed to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The country has a high prevalence of digestive and intestinal disorders, which has created a significant demand for related remedies. Factors such as a sedentary lifestyle, unhealthy dietary habits, and stress contribute to the high incidence of these conditions. The availability of a wide range of digestive and intestinal remedies in pharmacies across the country has made it convenient for consumers to access the products they need to manage their conditions. Underlying macroeconomic factors have played a role in the growth of the Digestive & Intestinal Remedies (Pharmacies) market in Oman. The country has experienced economic growth and an improvement in living standards, which has increased the affordability of healthcare products. Additionally, the government has invested in healthcare infrastructure and initiatives to improve access to healthcare services, including pharmacies. These factors have contributed to an increase in the demand for digestive and intestinal remedies as consumers have greater access to healthcare resources. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Oman is developing due to customer preferences for natural remedies, a shift towards self-care and preventive healthcare, local special circumstances such as a high prevalence of digestive and intestinal disorders, and underlying macroeconomic factors including economic growth and improved access to healthcare resources.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)